Travere Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

215,951

Value ($000)

8,251

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,251	0.0%	215,951	12/31/2025
2025 Q3	11/14/2025	3,488	0.0%	145,927	9/30/2025
2025 Q2	8/14/2025	6,594	0.0%	445,557	6/30/2025
2025 Q1	5/19/2025	1,193	0.0%	66,597	3/31/2025
2024 Q4	2/14/2025	2,815	0.0%	161,603	12/31/2024
2024 Q3	11/14/2024	2,283	0.0%	163,175	9/30/2024
2024 Q2	8/14/2024	1,469	0.0%	178,749	6/30/2024
2024 Q1	5/15/2024	802	0.0%	103,980	3/31/2024
2023 Q4	2/14/2024	894	0.0%	99,425	12/31/2023
2023 Q3	11/13/2023	889	0.0%	99,425	9/30/2023
2023 Q2	8/11/2023	1,991	0.0%	88,545	6/30/2023
2023 Q1	5/15/2023	1,991	0.0%	88,545	3/31/2023
2022 Q4	2/14/2023	1,337	0.0%	63,578	12/31/2022
2022 Q3	11/14/2022	1,538	0.0%	62,426	9/30/2022
2022 Q2	8/12/2022	1,603	0.0%	66,165	6/30/2022
2022 Q1	5/16/2022	1,731	0.0%	67,181	3/31/2022
2021 Q4	2/14/2022	1,961	0.0%	63,188	12/31/2021
2021 Q3	11/15/2021	1,256	0.0%	51,775	9/30/2021
2021 Q2	8/16/2021	781	0.0%	53,554	6/30/2021
2021 Q1	5/14/2021	1,233	0.0%	49,385	3/31/2021
2020 Q4	3/1/2021	1,054	0.0%	38,685	12/31/2020